Acadia Pharmaceuticals | ACAD - Marktkapitalisierung

Aktienkurs
21.96
Täglich Wechseln
-0.15 -0.68%
Monatlich
-0.23%
Jährlich
49.08%
Q2 Prognose
21.49




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cara Therapeutics USD 366M 338M 2025-09
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Incyte USD 19.39B 2.83B 2025-12
J&J USD 561.65B 17.5B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Prothena USD 514M 11M 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12